Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 08-2021 | 08-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,338 | 2,815 | 6,888 | 6,629 | 2,142 |
| Marketable Securities | N/A | 7,611 | 9,150 | 3,436 | N/A |
| Other current assets | 0 | 0 | 1,495 | 0 | 0 |
| TOTAL | $2,557 | $10,980 | $18,322 | $10,317 | $2,337 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 102 | 24 | 63 | 279 | 0 |
| TOTAL | $2,141 | $2,063 | $2,102 | $2,318 | $2,039 |
| Total Assets | $4,698 | $13,043 | $20,424 | $12,635 | $4,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,740 | 1,268 | 958 | 498 | 501 |
| TOTAL | $1,772 | $1,291 | $998 | $526 | $501 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 0 | 23 | 67 | 0 |
| TOTAL | $69 | $N/A | $23 | $67 | $N/A |
| Total Liabilities | $1,841 | $1,291 | $1,021 | $593 | $501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 547 | 538 | 476 | N/A | N/A |
| Common Shares | 3 | 3 | 3 | 2 | 5 |
| Retained earnings | -50,136 | -40,310 | -31,021 | -16,903 | -9,466 |
| Other shareholders' equity | -202 | -203 | -254 | 18 | 64 |
| TOTAL | $2,857 | $11,752 | $19,403 | $12,042 | $3,875 |
| Total Liabilities And Equity | $4,698 | $13,043 | $20,424 | $12,635 | $4,376 |